{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:13Z","timestamp":1772119273762,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science, and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["III41018"],"award-info":[{"award-number":["III41018"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00296-019-04246-3","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T18:00:47Z","timestamp":1548352847000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The association of CAT-262C\/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-561X","authenticated-orcid":false,"given":"Jelena","family":"Ba\u0161i\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-3370","authenticated-orcid":false,"given":"Jelena","family":"Vojinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0600-5411","authenticated-orcid":false,"given":"Tatjana","family":"Jevtovi\u0107-Stoimenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-3398","authenticated-orcid":false,"given":"Milena","family":"Despotovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7759-9344","authenticated-orcid":false,"given":"Tatjana","family":"Cvetkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-2859","authenticated-orcid":false,"given":"Dragana","family":"Lazarevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-831X","authenticated-orcid":false,"given":"Gordana","family":"Su\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-8277","authenticated-orcid":false,"given":"Vuk","family":"Milo\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-3280","authenticated-orcid":false,"given":"Mina","family":"Cvetkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-8853","authenticated-orcid":false,"given":"Du\u0161ica","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"issue":"2","key":"4246_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"12","key":"4246_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907\u2013916. https:\/\/doi.org\/10.1056\/NEJM200103223441207","journal-title":"N Engl J Med"},{"issue":"2","key":"4246_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2298\/JMH0202069P","volume":"21","author":"D Pavlovi\u0107","year":"2002","unstructured":"Pavlovi\u0107 D, \u0110or\u0111evi\u0107 V, Koci\u0107 G (2002) Signal transduction\u2014free radical modulation. Jugoslov Med Biohem 21(2):69\u201384. https:\/\/doi.org\/10.2298\/JMH0202069P","journal-title":"Jugoslov Med Biohem"},{"issue":"3","key":"4246_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00296-012-2430-4","volume":"33","author":"S Umar","year":"2013","unstructured":"Umar S, Kumar A, Sajad M, Zargan J, Ansari M, Ahmad S et al (2013) Hesperidin inhibits collagen-induced arthritis possibly through suppression of free radical load and reduction in neutrophil activation and infiltration. Rheumatol Int 33(3):657\u2013663. https:\/\/doi.org\/10.1007\/s00296-012-2430-4","journal-title":"Rheumatol Int"},{"issue":"3","key":"4246_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00296-007-0419-1","volume":"28","author":"Y Kageyama","year":"2008","unstructured":"Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A (2008) Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int 28(3):245\u2013251. https:\/\/doi.org\/10.1007\/s00296-007-0419-1","journal-title":"Rheumatol Int"},{"issue":"4","key":"4246_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.14712\/fb2014060040153","volume":"60","author":"J Kodydkov\u00e1","year":"2014","unstructured":"Kodydkov\u00e1 J, V\u00e1vrov\u00e1 L, Koc\u00edk M, \u017d\u00e1k A (2014) Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia Biol (Praha) 60(4):153\u2013167","journal-title":"Folia Biol (Praha)"},{"issue":"2","key":"4246_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2223\/JPED.45","volume":"76","author":"VA Ramos","year":"2000","unstructured":"Ramos VA, Ramos PA, Dominguez MC (2000) Role of oxidative stress in the maintenance of inflammation in patients with juvenile rheumatoid arthritis. J Pediatr 76(2):125\u2013132","journal-title":"J Pediatr"},{"issue":"2","key":"4246_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/096374800100787","volume":"51","author":"M Ashour","year":"2000","unstructured":"Ashour M, Salem S, Hassaneen H, El-Gadban H, Elwan N, Awad A, Basu TK (2000) Antioxidant status in children with juvenile rheumatoid arthritis (JRA) living in Cairo, Egypt. Int J Food Sci Nutr 51(2):85\u201390","journal-title":"Int J Food Sci Nutr"},{"issue":"4","key":"4246_CR9","first-page":"433","volume":"14","author":"M Sklodowska","year":"1996","unstructured":"Sklodowska M, Gromadzinska J, Biernacka M, Wasowicz W, Wolkanin P, Marszalek A et al (1996) Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 14(4):433\u2013439","journal-title":"Clin Exp Rheumatol"},{"key":"4246_CR10","unstructured":"Ensembl base (2018) Transcript: CAT-201. http:\/\/www.ensembl.org\/Homo_sapiens\/Transcript\/Summary?db=core;g=ENSG00000121691;r=11:34438925-34472062;t=ENST00000241052 . Accessed 22 Oct 2018"},{"issue":"1","key":"4246_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1262-3636(07)70248-3","volume":"32","author":"A Chistiakov","year":"2006","unstructured":"Chistiakov A, Zotova EV, Savos\u0165anov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV (2006) The 262T> C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 32(1):63\u201368","journal-title":"Diabetes Metab"},{"issue":"13","key":"4246_CR12","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1097\/MD.0000000000000679","volume":"94","author":"Y Shen","year":"2015","unstructured":"Shen Y, Li D, Tian P, Shen K, Zhu J, Feng M et al (2015) The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis. Medicine (Baltimore) 94(13):e679\u2013e686. https:\/\/doi.org\/10.1097\/MD.0000000000000679","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4246_CR13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1055-9965.EPI-07-2755","volume":"17","author":"SK Quick","year":"2008","unstructured":"Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD et al (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17(5):1082\u20131087. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-2755","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"4246_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/10715760903402906","volume":"44","author":"S Ezzikouri","year":"2010","unstructured":"Ezzikouri S, El Feydi AE, Afifi R, Benazzouz M, Hassar M, Pineau P, Benjelloun S (2010) Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population. Free Radic Res 44(2):208\u2013216. https:\/\/doi.org\/10.3109\/10715760903402906","journal-title":"Free Radic Res"},{"issue":"5","key":"4246_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/jgh.12141","volume":"28","author":"S Khodayari","year":"2013","unstructured":"Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei Gisomi N, Torabi Dalivandan S (2013) Catalase gene C-262T polymorphism: importance in ulcerative colitis. J Gastroenterol Hepatol 28(5):819\u2013822. https:\/\/doi.org\/10.1111\/jgh.12141","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"4246_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/MCO.0b013e328354a326","volume":"15","author":"M Hebert-Schuster","year":"2012","unstructured":"Hebert-Schuster M, Fabre EE, Nivet-Antoine V (2012) Catalase polymorphisms and metabolic diseases. Curr Opin Clin Nutr Metab Care 15(4):397\u2013402. https:\/\/doi.org\/10.1097\/MCO.0b013e328354a32","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"4246_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-017-1462-2","volume":"19","author":"G Horneff","year":"2017","unstructured":"Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I et al (2017) Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. Arthritis Res Ther 19(1):256. https:\/\/doi.org\/10.1186\/s13075-017-1462-2","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4246_CR18","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40(7):1202\u20131209","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4246_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0891-5849(00)00487-1","volume":"30","author":"L Forsberg","year":"2001","unstructured":"Forsberg L, Lyrenas L, de Faire U, Morgenstern R (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30(5):500\u2013505","journal-title":"Free Radic Biol Med"},{"issue":"2\u20133","key":"4246_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(91)90067-M","volume":"196","author":"L Goth","year":"1991","unstructured":"Goth L (1991) A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196(2\u20133):143\u2013152","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4246_CR21","first-page":"499","volume":"105","author":"S Go\u0163ia","year":"2001","unstructured":"Go\u0163ia S, Popovici I, Hermeziu B (2001) Antioxidant enzymes levels in children with juvenile rheumatoid arthritis. Rev Med Chir Soc Med Nat Iasi 105(3):499\u2013503","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"4246_CR22","doi-asserted-by":"publisher","first-page":"7157169","DOI":"10.1155\/2016\/7157169","volume":"2016","author":"K Winsz-Szczotka","year":"2016","unstructured":"Winsz-Szczotka K, Ku\u017anik-Trocha K, Komosi\u0144ska-Vassev K, Jura-P\u00f3Btorak A, Olczyk K (2016) Laboratory indicators of aggrecan turnover in juvenile idiopathic arthritis. Dis Markers 2016:7157169. https:\/\/doi.org\/10.1155\/2016\/7157169","journal-title":"Dis Markers"},{"issue":"1\u20132","key":"4246_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/biof.5520080126","volume":"8","author":"V Araujo","year":"1998","unstructured":"Araujo V, Arnal C, Boronat M, Ruiz E, Dominguez C (1998) Oxidant\u2013antioxidant imbalance in blood of children with juvenile rheumatoid arthritis. Biofactors 8(1\u20132):155\u2013159","journal-title":"Biofactors"},{"issue":"9","key":"4246_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.clinbiochem.2014.01.027","volume":"47","author":"K Winsz-Szczotka","year":"2014","unstructured":"Winsz-Szczotka K, Komosi\u0144ska-Vassev K, Ku\u017anik-Trocha K, Gruenpeter A, Lach\u00f3r-Motyka I, Olczyk K (2014) Influence of proteolytic\u2013antiproteolytic enzymes and prooxidative\u2013antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis. Clin Biochem 47(9):829\u2013834. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.01.027","journal-title":"Clin Biochem"},{"issue":"4","key":"4246_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48(4):1093\u20131101. https:\/\/doi.org\/10.1002\/art.10885","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4246_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00296-009-0942-3","volume":"30","author":"M Halbig","year":"2009","unstructured":"Halbig M, Horneff G (2009) Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept. Rheumatol Int 30(2):229\u2013238. https:\/\/doi.org\/10.1007\/s00296-009-0942-3","journal-title":"Rheumatol Int"},{"issue":"11","key":"4246_CR27","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.febslet.2010.04.048","volume":"584","author":"JY Min","year":"2010","unstructured":"Min JY, Lim SO, Jung G (2010)) Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett 584(11):2427\u20132432. https:\/\/doi.org\/10.1016\/j.febslet.2010.04.048","journal-title":"FEBS Lett"},{"issue":"1","key":"4246_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-017-0178-9","volume":"15","author":"EI Alexeeva","year":"2017","unstructured":"Alexeeva EI, Namazova-Baranova LS, Bzarova TM, Valieva SI, Denisova RV, Sleptsova TV et al (2017) Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children\u2019s Health, Russia. Pediatr Rheumatol Online J 15(1):51. https:\/\/doi.org\/10.1186\/s12969-017-0178-9","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"4246_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/14397595.2017.1366006","volume":"28","author":"G Murdaca","year":"2018","unstructured":"Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R et al (2018) Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Mod Rheumatol 28(3):417\u2013431. https:\/\/doi.org\/10.1080\/14397595.2017.1366006","journal-title":"Mod Rheumatol"},{"issue":"6","key":"4246_CR30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3899\/jrheum.121281","volume":"40","author":"S Sanctis De","year":"2013","unstructured":"De Sanctis S, Marcovecchio ML, Gaspari S, Del Torto M, Mohn A, Chiarelli F et al (2013) Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis. J Rheumatol 40(6):943\u2013948. https:\/\/doi.org\/10.3899\/jrheum.121281","journal-title":"J Rheumatol"},{"issue":"11","key":"4246_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/archdischild-2018-315528","volume":"103","author":"H Hunter","year":"2018","unstructured":"Hunter H (2018) Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis? Arch Dis Child 103(11):1087\u20131089. https:\/\/doi.org\/10.1136\/archdischild-2018-315528","journal-title":"Arch Dis Child"},{"key":"4246_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1516329","author":"E Alexeeva","year":"2018","unstructured":"Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A, Fetisova A, Mamutova A, Alshevskaya A, Gladkikh V, Moskalev A (2018) Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method. Mod Rheumatol. https:\/\/doi.org\/10.1080\/14397595.2018.1516329","journal-title":"Mod Rheumatol"},{"issue":"2","key":"4246_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13105-010-0022-x","volume":"66","author":"J Basic","year":"2010","unstructured":"Basic J, Pavlovic D, Jevtovic-Stoimenov T, Vojinovic J, Susic G, Stojanovic I et al (2010) Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-\u03b1-308GG genotype. J Physiol Biochem 66(2):173\u2013180. https:\/\/doi.org\/10.1007\/s13105-010-0022-x","journal-title":"J Physiol Biochem"},{"key":"4246_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4264-2","author":"J Ba\u0161i\u0107","year":"2018","unstructured":"Ba\u0161i\u0107 J, Vojinovi\u0107 J, Jevtovi\u0107-Stoimenov T, Despotovi\u0107 M, Su\u0161i\u0107 G, Lazarevi\u0107 D et al (2018) Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-018-4264-2","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4246_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3899\/jrheum.150430","volume":"43","author":"T Constantin","year":"2016","unstructured":"Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I et al (2016) Two-year efficacy and safety of etanercept in pediatric patients with extended oligoarthritis, enthesitis-related arthritis, or psoriatic arthritis. J Rheumatol 43(4):816\u2013824. https:\/\/doi.org\/10.3899\/jrheum.150430","journal-title":"J Rheumatol"},{"issue":"5","key":"4246_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12199-016-0540-4","volume":"21","author":"K Saify","year":"2016","unstructured":"Saify K, Saadat I, Saadat M (2016) Influence of A-21T and C-262T genetic polymorphisms at the promoter region of the catalase (CAT) on gene expression. Environ Health Prev Med 21(5):382\u2013386. https:\/\/doi.org\/10.1007\/s12199-016-0540-4","journal-title":"Environ Health Prev Med"},{"issue":"2","key":"4246_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10067-007-0746-3","volume":"27","author":"B Kalpakcioglu","year":"2008","unstructured":"Kalpakcioglu B, Enel K (2008) The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 27(2):141\u2013145. https:\/\/doi.org\/10.1007\/s10067-007-0746-3","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04246-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:34:44Z","timestamp":1720935284000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4246"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04246-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734926454.793582463","asserted-by":"object"}]},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study. All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}